Patents by Inventor Arthur Louie

Arthur Louie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders
    Patent number: 8092828
    Abstract: Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: January 10, 2012
    Assignee: Celator Pharmaceuticals, Inc.
    Inventors: Arthur Louie, Christine Swenson, Lawrence Mayer, Andrew Janoff
  • FIXED DRUG RATIOS FOR TREATMENT OF HEMATOPOIETIC CANCERS AND PROLIFERATIVE DISORDERS
    Publication number: 20100303895
    Abstract: Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders.
    Type: Application
    Filed: February 15, 2008
    Publication date: December 2, 2010
    Inventors: Arthur Louie, Christine Swenson, Lawrence Mayer, Andrew Janoff
  • FIXED DRUG RATIOS FOR TREATMENT OF HEMATOPOIETIC CANCERS AND PROLIFERATIVE DISORDERS
    Publication number: 20080199515
    Abstract: Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders.
    Type: Application
    Filed: February 15, 2008
    Publication date: August 21, 2008
    Inventors: Arthur Louie, Christine Swenson, Lawrence Mayer, Andrew Janoff
  • Therapeutic uses of keratinocyte growth factor-2
    Patent number: 6599879
    Abstract: The present invention relates to the administration of Keratinocyte Growth Factor-2 (KGF-2) to stimulate proliferation of platelets and to increase levels of fibrinogen, albumin, globulin and total serum protein. Further, the present invention relates to administering KGF-2 to protect or treat the bladder and prostate. Moreover, the present invention relates to administering KGF-2 to stimulate growth of nasal, oral, and esophageal mucosa, lacrimal glands, salivary glands and Goblet cells.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: July 29, 2003
    Assignee: Human Genome Sciences, Inc.
    Inventors: Pablo Jimenez, Mark A. Rampy, Donna Mendrick, Deborah Russell, Arthur Louie